APA (7th ed.) Citation

Cotté, F., Benhaddi, H., Duprat-Lomon, I., Doble, A., Marchant, N., Letierce, A., & Huguet, M. (2014). Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries. Clinical Therapeutics, 36(9), 1160. https://doi.org/10.1016/j.clinthera.2014.07.016

Chicago Style (17th ed.) Citation

Cotté, François-Emery, Hicham Benhaddi, Isabelle Duprat-Lomon, Adam Doble, Nick Marchant, Alexia Letierce, and Michael Huguet. "Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries." Clinical Therapeutics 36, no. 9 (2014): 1160. https://doi.org/10.1016/j.clinthera.2014.07.016.

MLA (9th ed.) Citation

Cotté, François-Emery, et al. "Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries." Clinical Therapeutics, vol. 36, no. 9, 2014, p. 1160, https://doi.org/10.1016/j.clinthera.2014.07.016.